GlassScriptPhysician profile
Madeline Mee
NPI 1366224792
$1,338.32
in general payments reported to CMS, 2019-2025
16 companies · $782 in 2025
The $782 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $115 · 2024: $441 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.26 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $485.34 | 2024-2025 | Erleada, Carvykti, Rybrevant |
| Boston Scientific Corporation | $132.51 | 2024 | Ams 700 |
| Idorsia Pharmaceuticals US INC | $115.16 | 2023 | Quviviq |
| Aveo Pharmaceuticals, INC. | $113.11 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $82.53 | 2024-2025 | Lynparza, Imfinzi |
| Progenics Pharmaceuticals, INC. | $80.74 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $51.56 | 2024 | Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $46.44 | 2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $45.69 | 2025 | |
| Immunitybio, INC. | $45.55 | 2024-2025 | |
| Urogen Pharma, INC. | $34.90 | 2024-2025 | |
| Tolmar, INC. | $23.43 | 2024 | |
| Myriad Genetic Laboratories, INC. | $22.29 | 2025 | Prolaris |
| Incyte Corporation | $21.17 | 2025 | Jakafi |
| Sun Pharmaceutical Industries INC. | $20.04 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.86 | 2025 | Fruzaqla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Mee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.